PARP inhibitors in pancreatic cancer: molecular mechanisms and clinical applications
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-4598
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
PARP inhibitors in pancreatic cancer: molecular mechanisms and clinical applications ; volume:19 ; number:1 ; day:2 ; month:3 ; year:2020 ; pages:1-15 ; date:12.2020
Molecular cancer ; 19, Heft 1 (2.3.2020), 1-15, 12.2020
- Creator
-
Zhu, Heng
Wei, Miaoyan
Xu, Jin
Hua, Jie
Liang, Chen
Meng, Qingcai
Zhang, Yiyin
Liu, Jiang
Zhang, Bo
Yu, Xianjun
Shi, Si
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12943-020-01167-9
- URN
-
urn:nbn:de:101:1-2020052417231420766990
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 14.08.2025, 11:04 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zhu, Heng
- Wei, Miaoyan
- Xu, Jin
- Hua, Jie
- Liang, Chen
- Meng, Qingcai
- Zhang, Yiyin
- Liu, Jiang
- Zhang, Bo
- Yu, Xianjun
- Shi, Si
- SpringerLink (Online service)
Other Objects (12)
The reciprocal regulation between host tissue and immune cells in pancreatic ductal adenocarcinoma: new insights and therapeutic implications
Ferroptosis, necroptosis, and pyroptosis in anticancer immunity
A PD-L2-based immune marker signature helps to predict survival in resected pancreatic ductal adenocarcinoma
The microbiota and microbiome in pancreatic cancer: more influential than expected
Turning up the heat on non-immunoreactive tumors: autophagy influences the immune microenvironment in pancreatic cancer
Comprehensive analysis of the prognosis and immune infiltration landscape of RNA methylation-related subtypes in pancreatic cancer
The promising role of noncoding RNAs in cancer-associated fibroblasts: an overview of current status and future perspectives
Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives
Role of tumor mutation burden-related signatures in the prognosis and immune microenvironment of pancreatic ductal adenocarcinoma
Circular RNA CircEYA3 induces energy production to promote pancreatic ductal adenocarcinoma progression through the miR-1294/c-Myc axis
Radical antegrade modular pancreatosplenectomy (RAMPS) versus standard retrograde pancreatosplenectomy (SRPS) for resectable body and tail pancreatic adenocarcinoma: protocol of a multicenter, prospective, randomized phase III control trial (CSPAC-3)
Topical application of Glauber’s salt accelerates the absorption of abdominal fluid after pancreatectomy
The reciprocal regulation between host tissue and immune cells in pancreatic ductal adenocarcinoma: new insights and therapeutic implications
Ferroptosis, necroptosis, and pyroptosis in anticancer immunity
A PD-L2-based immune marker signature helps to predict survival in resected pancreatic ductal adenocarcinoma
The microbiota and microbiome in pancreatic cancer: more influential than expected
Turning up the heat on non-immunoreactive tumors: autophagy influences the immune microenvironment in pancreatic cancer
Comprehensive analysis of the prognosis and immune infiltration landscape of RNA methylation-related subtypes in pancreatic cancer
The promising role of noncoding RNAs in cancer-associated fibroblasts: an overview of current status and future perspectives
Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives
Role of tumor mutation burden-related signatures in the prognosis and immune microenvironment of pancreatic ductal adenocarcinoma
Circular RNA CircEYA3 induces energy production to promote pancreatic ductal adenocarcinoma progression through the miR-1294/c-Myc axis
Radical antegrade modular pancreatosplenectomy (RAMPS) versus standard retrograde pancreatosplenectomy (SRPS) for resectable body and tail pancreatic adenocarcinoma: protocol of a multicenter, prospective, randomized phase III control trial (CSPAC-3)
Topical application of Glauber’s salt accelerates the absorption of abdominal fluid after pancreatectomy
The reciprocal regulation between host tissue and immune cells in pancreatic ductal adenocarcinoma: new insights and therapeutic implications
Ferroptosis, necroptosis, and pyroptosis in anticancer immunity
A PD-L2-based immune marker signature helps to predict survival in resected pancreatic ductal adenocarcinoma
The microbiota and microbiome in pancreatic cancer: more influential than expected
Turning up the heat on non-immunoreactive tumors: autophagy influences the immune microenvironment in pancreatic cancer
Comprehensive analysis of the prognosis and immune infiltration landscape of RNA methylation-related subtypes in pancreatic cancer
The promising role of noncoding RNAs in cancer-associated fibroblasts: an overview of current status and future perspectives
Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives
Role of tumor mutation burden-related signatures in the prognosis and immune microenvironment of pancreatic ductal adenocarcinoma
Circular RNA CircEYA3 induces energy production to promote pancreatic ductal adenocarcinoma progression through the miR-1294/c-Myc axis
Radical antegrade modular pancreatosplenectomy (RAMPS) versus standard retrograde pancreatosplenectomy (SRPS) for resectable body and tail pancreatic adenocarcinoma: protocol of a multicenter, prospective, randomized phase III control trial (CSPAC-3)